SCHEMBL5484196

SCHEMBL5484196

CC(C=O)C=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL812256 0.76
SCHEMBL10491656 0.76
SCHEMBL8895945 0.72
SCHEMBL403755 0.69
SCHEMBL2358697 0.67
SCHEMBL7596024 0.65
SCHEMBL4354453 0.65
SCHEMBL1122011 0.65
SCHEMBL8008332 0.64
SCHEMBL9473178 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1233769-B1 Imidazole derivatives SMITHKLINE BEECHAM PLC (GB) 2007-12-26 EP disclosed
US-7189745-B1 Compounds SMITHKLINE BEECHAM CORPORATION (US) 2007-03-13 US disclosed
US-20070010534-A1 NOVEL COMPOUNDS SMITHKLINE BEECHAM CORPORATION 2007-01-11 US disclosed
EP-1233769-A4 NOVEL COMPOUNDS SMITHKLINE BEECHAM PLC (GB) 2004-12-29 EP disclosed
EP-1233769-A1 NOVEL COMPOUNDS SMITHKLINE BEECHAM PLC (GB) 2002-08-28 EP disclosed
WO-2001037835-A1 NOVEL COMPOUNDS SMITHKLINE BEECHAM PLC. (GB) 2001-05-31 WO disclosed